World's Best Scientists 2026 revealed!
Mari Mino-Kenudson

Mari Mino-Kenudson

Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
117
Citations
65976
World Ranking
632
National Ranking
384

Medicine

D-Index
119
Citations
68616
World Ranking
3833
National Ranking
2098

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Mari Mino-Kenudson is affiliated with Harvard University in the United States and has a comprehensive research portfolio in medicine, with a focus on oncology and pulmonary and respiratory medicine. Their scholarly contributions span various subfields including molecular biology, cancer research, and surgery.

The scientist's publication record shows primary involvement in topics such as pancreatic and hepatic oncology research, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, cancer genomics and diagnostics, lung cancer diagnosis and treatment, medical imaging and pathology studies, and pancreatitis pathology and treatment.

Some of the recent papers authored or co-authored by Mino-Kenudson include:

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment, 2022, Nature Genetics
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers, 2020, Modern Pathology
  • Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms, 2021, Cancer Cell

Frequent co-authors who have collaborated extensively with Mino-Kenudson include Carlos Fernández-del Castillo, Justin F. Gainor, Yin P. Hung, David T. Ting, and Jaimie L. Barth.

The scientist's work has been published predominantly in notable journals such as the Journal of Thoracic Oncology, Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Histopathology, and Gastroenterology.

Mari Mino-Kenudson's research impact is reflected in their extensive publication count within the main fields of medicine and biochemistry, genetics, and molecular biology. Their research addresses critical areas in oncology, particularly involving lung and pancreatic cancer, combining clinical and molecular approaches to improve understanding and treatment.

Best Publications

  • Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  • Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

    Lecia V. Sequist;Belinda A. Waltman;Dora Dias-Santagata;Subba Digumarthy

  • Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Alice T. Shaw;Beow Y. Yeap;Mari Mino-Kenudson;Subba R. Digumarthy

  • ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

    Kristin Bergethon;Alice T. Shaw;Sai Hong Ignatius Ou;Ryohei Katayama

  • Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

    Richard Possemato;Kevin M. Marks;Yoav D. Shaul;Michael E. Pacold

  • International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.

    Tooru Shimosegawa;Suresh T. Chari;Luca Frulloni;Terumi Kamisawa

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

    Jean Nicolas Vauthey;Timothy M. Pawlik;Dario Ribero;Tsung Teh Wu

  • Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

    Ryohei Katayama;Alice T. Shaw;Alice T. Shaw;Tahsin M. Khan;Tahsin M. Khan;Mari Mino-Kenudson

  • Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

    Justin F. Gainor;Leila Dardaei;Satoshi Yoda;Luc Friboulet

  • EGFR Mutations and ALK Rearrangements Are Associated With Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis

    Justin F. Gainor;Alice T. Shaw;Lecia V. Sequist;Xiujun Fu

  • EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

    Ryan B. Corcoran;Hiromichi Ebi;Alexa B. Turke;Erin M. Coffee

  • Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

    Christina Pfirschke;Camilla Engblom;Steffen Rickelt;Virna Cortez-Retamozo

  • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

    Scott J. Rodig;Mari Mino-Kenudson;Sanja Dacic;Beow Y. Yeap

  • mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake

    Ömer H. Yilmaz;Pekka Katajisto;Dudley W. Lamming;Yetis Gültekin;Yetis Gültekin

  • Patient-derived models of acquired resistance can identify effective drug combinations for cancer

    Adam S. Crystal;Alice T. Shaw;Lecia V. Sequist;Luc Friboulet

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer

    Justin F. Gainor;Anna M. Varghese;Sai-Hong Ignatius Ou;Sheheryar Kabraji

  • RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

    Matthew J. Niederst;Lecia V. Sequist;John T. Poirier;Craig H. Mermel

  • Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure

    Cristina R. Ferrone;Rafael Pieretti-Vanmarcke;Jordan P. Bloom;Hui Zheng

Frequent Co-Authors

William R. Brugge
William R. Brugge Harvard University
Andrew L. Warshaw
Andrew L. Warshaw Harvard University
Keith D. Lillemoe
Keith D. Lillemoe Harvard University
Jeffrey A. Engelman
Jeffrey A. Engelman Novartis Institutes for BioMedical Research (NIBR)
Alice T. Shaw
Alice T. Shaw Harvard University
Gregory Y. Lauwers
Gregory Y. Lauwers Harvard University
Cristina R. Ferrone
Cristina R. Ferrone Harvard University
Justin F. Gainor
Justin F. Gainor Harvard University
A. John Iafrate
A. John Iafrate Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in the medical field but not committed to a traditional path like medical school, a range of online degrees and alternative career pathways are available. Many choose direct entry nurse practitioner programs for non-nurses online, which allow those with non-nursing bachelor’s degrees to become advanced practice nurses through accelerated study.

For those seeking shorter or more accessible options, some online adn programs provide a path to becoming a registered nurse. These programs typically feature flexible admission requirements and are designed for people at different educational backgrounds.

Not all roles in healthcare require clinical training. Careers in health administration and technology are growing fast. For example, you might consider medical billing and coding schools online to enter a vital part of healthcare operations, often with remote work possibilities.

Finally, some nursing programs make entry easier by eliminating standardized entrance tests. Consider applying to a nursing school that doesn't require teas, reducing the barriers to starting your health care journey.

Best Scientists Citing Mari Mino-Kenudson

Trending Scientists